Full Text
PND29 THE COST OF ACHIEVING NEDA WHILE USING TWO ALTERNATIVE FORMULATIONS OF INTERFERON BETA-1A FOR THE TREATMENT OF MULTIPLE SCLEROSIS IN PORTUGAL: LET'S LOOK AT EVIDENCE

Abstract

Authors

N. Silverio A. Fonseca G. Amorim

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×